Home
>
National Drug Code (NDC)
>
Dilantin
Dilantin - 0071-3740-66 - (PHENYTOIN SODIUM)
Drug Information of Dilantin
| Product NDC: | 0071-3740 |
| Proprietary Name: | Dilantin |
| Non Proprietary Name: | PHENYTOIN SODIUM |
| Active Ingredient(s): | 30 mg/1 & nbsp; PHENYTOIN SODIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dilantin
| Product NDC: | 0071-3740 |
| Labeler Name: | Parke-Davis Div of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA084349 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19760827 |
Package Information of Dilantin
| Package NDC: | 0071-3740-66 |
| Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0071-3740-66) |
NDC Information of Dilantin
| NDC Code | 0071-3740-66 |
| Proprietary Name | Dilantin |
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0071-3740-66) |
| Product NDC | 0071-3740 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PHENYTOIN SODIUM |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19760827 |
| Marketing Category Name | ANDA |
| Labeler Name | Parke-Davis Div of Pfizer Inc |
| Substance Name | PHENYTOIN SODIUM |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
